Cellosaurus cell line NT-32 (CVCL

Cross-references
Cell line name	NT-32
Accession	CVCL_C4N8
Resource Identification Initiative	To cite this cell line use: NT-32 (RRID:CVCL_C4N8)
Comments	Doubling time: 5.35 days (PubMed=36269546). Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
Sequence variations	Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Asn486_Pro490del (c.1457_1471del); ClinVar=VCV000666267; Zygosity=Unspecified (PubMed=36269546). Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Unspecified (PubMed=36269546).
Disease	Pancreatic large cell neuroendocrine carcinoma (NCIt: C95582)
Species of origin	Homo sapiens (Human) (NCBI Taxonomy: 9606)
Sex of cell	Female
Age at sampling	70Y
Category	Cancer cell line
Publications	PubMed=36269546; DOI=10.1007/s13402-022-00727-z; PMCID=PMC9747820 Fabrice Viol, Bence Sipos, Martina Fahl, Till Sebastian Clauditz, Tania Amin, Malte Kriegs, Maike Nieser, Jakob Robert Izbicki, Samuel Huber, Ansgar W. Lohse, Jorg Schrader; Novel preclinical gastroenteropancreatic neuroendocrine neoplasia models demonstrate the feasibility of mutation-based targeted therapy. Cell. Oncol. (Dordr.) 45:1401-1419(2022)
Encyclopedic resources	Wikidata; Q116050016
Entry history
Entry creation	15-Dec-2022
Last entry update	19-Dec-2024
Version number	4